A recent study supports the consideration of miR-221 as a potential treatment for PD due to its protective role by regulating PC12 cell viability and apoptosis by targeting phosphatase and tensin homolog (PTEN) [243]. The gene discussed is PTEN; the disease is Parkinson disease.